FAETH news

Latest 1 stories · newest Nov 9, 2026

FAETH

Faeth Releases PIKTOR Phase 2 Results in Endometrial Cancer

Faeth Therapeutics announced preliminary Phase 2 data for PIKTOR in combination with paclitaxel for advanced endometrial cancer, highlighting top-line results and the presentation of efficacy-evaluable analyses.

Regulatory Nov 9, 2026 sentiment +0.50 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same FAETH feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/FAETH/newsSTART FREE